Get Live Data

Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Immupharma Share Price
  4. Immupharma Share News
  5. IN BRIEF: Immupharma Repays Lind Global Convertible Security

Pin to quick picksImmupharma Share News (IMM)

Immupharma Information

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.24
Bid: 2.11
Ask: 2.25
Change: 0.035 (1.59%)
Spread: 0.14 (6.635%)
Open: 2.20
High: 2.24
Low: 2.20
Prev. Close: 2.205
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Immupharma Repays Lind Global Convertible Security

Tue, 22nd Sep 2020 21:17

Immupharma PLC - pharmaceutical company - Says lender Lind Global Macro Fund LP has requested repayment of its part of convertible security. Immupharma repays USD1.1 million, with USD355.113 outstanding. "Following the repayment the company still expects to have sufficient cash resources to fund operations through the end of 2023," Immupharma said.

Current stock price: 11.25 pence

Year-to-date change: down 30%

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
4 Nov 2015 10:44

ImmuPharma's Lupuzor trial on track for 2017 completion

(ShareCast News) - ImmuPharma has reached a number of important milestones in the phase three clinical trial of Lupuzor. The AIM listed company provided an update to the market on Wednesday about the drug trial, its lead programme for the potential breakthrough compound for life threatening auto imm

Read more
4 Nov 2015 10:31

WINNERS & LOSERS SUMMARY: Housebuilders And Estate Agents Torn Down

Read more
4 Nov 2015 08:56

ImmuPharma Says Lupuzor Trials Set To Start In US This Year

Read more
30 Sep 2015 09:29

ImmuPharma Appoints Non-Executive Chairman As Loss Narrows

Read more
29 Jul 2015 09:16

ImmuPharma Says Chairman And Co-Founder Richard Warr Dies

Read more
27 Jul 2015 07:08

ImmuPharma Secures Financing To Continue Lupuzor Progress (ALLISS)

Read more
29 May 2015 07:28

LONDON MORNING BRIEFING: AB Foods Lifted To Buy From Sell By Goldman

Read more
29 May 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
28 May 2015 16:28

AGM, EGM Calendar - Week Ahead

Read more
6 May 2015 08:11

ImmuPharma Chairman Takes Leave To Deal With Health Issue

Read more
30 Apr 2015 09:37

Immupharma To Focus On Lupuzor, 2014 Loss Narrows On Trial End

Read more
11 Feb 2015 12:18

Immupharma Says Cancer Therapy Trial Meets Primary Objective

Read more
22 Jan 2015 12:00

UK MIDDAY BRIEFING: Royal Mail Up As It Meets Low Expectations

Read more
22 Jan 2015 11:19

UK WINNERS & LOSERS: Oxford Instruments Falls On Another Warning

Read more
22 Jan 2015 08:32

ImmuPharma Shares Up 22% On Simbec-Orion Lupuzor Agreement

Read more
3456789101112

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.